Clinical Trial Update: A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating IL-7 to restore absolute lymphocyte counts in patients with severe sepsis and septic shock; study completed with results posted in 2020…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• IL-7 (interleukin-7)

Snippet

Sponsor: Revimmune | Conditions: Severe Sepsis With Septic Shock | Phase 2 | Status: COMPLETED | Results posted: 2020-07-09